Company Overview and News


Add PNV
to your dashboard

Headline News

Polynovo signs deal to launch its skin regeneration technology in Israel

2017-10-04 proactiveinvestors.com.au
Polynovo Ltd (ASX:PNV) has signed a distribution agreement with AMI Medical Technologies in Israel for its NovoSorb™ BTM tissue scaffold used for skin regeneration.

Polynovo follows swift re-rating with a capital raising

2017-09-22 proactiveinvestors.com.au
Polynovo Ltd's (ASX:PNV) shares last traded at $0.285, or around 60% higher than a month ago, with the company receiving a positive re-rating following its first U.S. sales of NovoSorb BTM™

Polynovo Ltd to divulge funding for non-clinical trial

2016-05-30 proactiveinvestors.com.au
PolyNovo (ASX:PNV) is a Melbourne-based regenerative medical device company that designs, develops and manufactures devices using its patented NovoSorb™ biodegradable polymer technology.

Release of shares from escrow

2016-05-13 asx.com.au

Appendix 3B

2016-04-15 asx.com.au

Appendix 3B

2016-02-23 asx.com.au

Half Yearly Report and Accounts

2016-02-19 asx.com.au

Financial Result Guidance

2016-02-12 asx.com.au

US FDA approval

2016-01-04 asx.com.au

PolyNovo's US FDA approval

2015-12-29 asx.com.au

Change in substantial holding

2015-12-29 asx.com.au

Change in substantial holding

2015-12-24 asx.com.au

Appendix 3B

2015-12-23 asx.com.au

Independent Valuation Report

2015-12-22 asx.com.au